Severe Hypoglycaemia In Patients With Diabetes — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for severe hypoglycaemia in patients with diabetes. 12 active patents protecting 1 drugs from 1+ originators. First major cliff: 2036. Daily refresh.

1
Approved drugs
12
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators in Severe Hypoglycaemia In Patients With Diabetes

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Xeris 12 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating severe hypoglycaemia in patients with diabetes. Each bar = one year. Y-axis scaled to peak year (11 patents).

11
36
1
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Glucagen
GLUCAGON
 Xeris 12 65 — 2036-02-16

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12370241 Glucagen method of use 75 2036-02-16
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
10213487 Glucagen method of use 62 2036-02-16
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10765602 Glucagen formulation 42 2039-09-23
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
9649364 Glucagen method of use 62 2036-04-22
10213487 Glucagen method of use 62 2036-02-16
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22
11590205 Glucagen method of use 70 2036-04-22

Related